Does Rallies show Form 4 insider transactions for TARA?

Yes. Rallies tracks TARA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is TARA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TARA. It does not provide personalized investment advice.

TARA (Protara Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades

Protara Therapeutics, Inc. Common Stock (TARA) is a publicly traded Healthcare sector company. As of May 21, 2026, TARA trades at $4.73 with a market cap of $258.54M and a P/E ratio of -3.52. TARA moved +9.91% today. Year to date, TARA is -11.69%; over the trailing twelve months it is +36.78%. Its 52-week range spans $1.60 to $10.48. Analyst consensus is strong buy with an average price target of $25.83. Rallies surfaces TARA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading TARA stock inside the company?

Recent TARA insider activity includes Zummo Jacqueline sold 1.13K, Zummo Jacqueline sold 22.60K, Levy Richard S bought 20.00K, Levy Richard S bought 20.00K, and Zummo Jacqueline sold 21.22K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

TARA Key Metrics

Key financial metrics for TARA
Metric	Value
Price	$4.73
Market Cap	$258.54M
P/E Ratio	-3.52
EPS	$-1.34
Dividend Yield	0.00%
52-Week High	$10.48
52-Week Low	$1.60
Volume	750
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-57.44M
Gross Margin	0.00%

Recent TARA Insider Trades

Zummo Jacqueline sold 1.13K (~$6.12K) on Apr 8, 2026.
Zummo Jacqueline sold 22.60K (~$118.87K) on Apr 1, 2026.
Levy Richard S bought 20.00K (~$63.80K) on May 14, 2025.
Levy Richard S bought 20.00K (~$63.80K) on May 14, 2025.
Zummo Jacqueline sold 21.22K (~$96.14K) on Mar 26, 2025.

Latest TARA News

Protara to Unveil 12-Month Interim Data from 31-Patient Phase 2 Bladder Cancer Trial — Apr 27, 2026
Protara Posts 68% Six-Month NMIBC Response, Plans 100-Patient Trial Expansion — Mar 2, 2026
Protara Highlights Strong Phase 2 TARA-002 Response Rates in NMIBC at ASCO GU — Feb 25, 2026
Protara’s TARA-002 Achieves 68% Six-Month NMIBC Response Rate — Feb 24, 2026

TARA Analyst Consensus

7 analysts cover TARA: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $25.83.

Common questions about TARA

Who is trading TARA stock inside the company?: Recent TARA insider activity includes Zummo Jacqueline sold 1.13K, Zummo Jacqueline sold 22.60K, Levy Richard S bought 20.00K, Levy Richard S bought 20.00K, and Zummo Jacqueline sold 21.22K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TARA?: Yes. Rallies tracks TARA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TARA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TARA. It does not provide personalized investment advice.